Compare BUR & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BUR | NEOG |
|---|---|---|
| Founded | 2009 | 1981 |
| Country | Guernsey | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2017 | 1995 |
| Metric | BUR | NEOG |
|---|---|---|
| Price | $8.77 | $11.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $18.00 | $10.67 |
| AVG Volume (30 Days) | 1.6M | ★ 2.6M |
| Earning Date | 05-27-2026 | 04-10-2026 |
| Dividend Yield | ★ 1.48% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.28 | 0.09 |
| Revenue | $413,360,000.00 | ★ $894,661,000.00 |
| Revenue This Year | $70.60 | N/A |
| Revenue Next Year | $19.62 | $1.67 |
| P/E Ratio | ★ $30.14 | $124.61 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.12 | $3.87 |
| 52 Week High | $14.61 | $11.43 |
| Indicator | BUR | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 41.53 | 66.35 |
| Support Level | $8.19 | $10.37 |
| Resistance Level | $9.79 | N/A |
| Average True Range (ATR) | 0.36 | 0.37 |
| MACD | -0.09 | -0.07 |
| Stochastic Oscillator | 34.53 | 73.85 |
Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.